NCT07617272 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07617272
Title	Prostate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScore (PARIS-BIO)
Acronym	PARIS-BIO
Recruitment	Recruiting
Gender	male
Phase	Phase II
Variant Requirements	No
Sponsors	Region Stockholm
Indications	prostate cancer
Therapies	Darolutamide
Age Groups:	adult \| senior
Covered Countries	SWE

Facility	Status	City	State	Zip	Country	Details
Sahlgrenska University Hospital	RECRUITING	Gothenburg			Sweden	Details
Karolinska University Hospital	RECRUITING	Stockholm		SE-17176	Sweden	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07617272Clinical Trial Detail